Current status of carbohydrate deficient transferrin, total serum sialic acid, sialic acid index of apolipoprotein J and serum β-hexosaminidase as markers for alcohol consumption

Addiction

Volumn 98, Issue SUPPL. 2, 2003, Pages 45-50

  Javors, Martin A ^a   Johnson, Bankole A ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

hexosaminidase; Alcohol consumption; Carbohydrate deficient transferring; Markers; Sialic acid

Indexed keywords

BETA N ACETYLHEXOSAMINIDASE; BIOCHEMICAL MARKER; CARBOHYDRATE DEFICIENT TRANSFERRIN; CLUSTERIN; SIALIC ACID;

ALCOHOL CONSUMPTION; BLOOD LEVEL; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; HUMAN; MEASUREMENT; REVIEW; SERUM;

ALCOHOL DRINKING; BETA-N-ACETYLHEXOSAMINIDASE; BIOLOGICAL MARKERS; CLUSTERIN; GLYCOPROTEINS; HUMANS; MOLECULAR CHAPERONES; N-ACETYLNEURAMINIC ACID; TRANSFERRIN;

EID: 0346199332     PISSN: 09652140     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1359-6357.2003.00582.x     Document Type: Review

References (48)

1. Stibler. H. & Borg, S. (1991) Glycoprotein glycosyltransferase activities in serum in alcohol-abusing patients and healthy controls. Scandinavian Journal of Clinical Laboratory Investigations, 51, 43-51.
2. Stibler, H., Allgulander, C., Borg, S. & Kjellin, K. G. (1978) Abnormal microheterogeneity of transferrin in serum and cerebrospinal fluid in alcoholism. Acta Medica Scandinavica, 204, 49-56.
3. Stibler, H. (1991) Carbohydrate-deficient transferrin in serum: a new marker of potentially harmful alcohol consumption reviewed. Clinical Chemistry, 37, 2029-2037.
4. Dibbelt, L. (2000) Does trisialo-transferrin provide valuable information for the laboratory diagnosis of chronically increased alcohol consumption by determination of CDT? Clinical Chemistry, 46, 1203-1205.
5. Lipkowski, M., Dibbelt, L. & Seyfarth, M. (2000) Is there an analytical or diagnostic advantage from including trisialo transferrin into the fraction of CDT? Lessons from a comparison of two commercial turbidimetric immunoassays with the CDT determination by HPLC. Clinical Biochemistry, 33, 635-641.
6. Lacey, J.M., Bergen, M., Magera, M. J., Naylor, S. & O'Brien, J. F. (2001) Rapid determination of transferrin isoforms by immunoaffinity liquid chromatography and electrospray mass spectrometry. Clinical Chemistry, 47, 513-518.
7. Jeppsson, J. O., Kristensson, H. & Fimiani, C. (1993) Carbohydrate-deficient transferrin quantified by HPLC to determine heavy consumption of alcohol. Clinical Chemistry, 39, 2115-2120.
8. Legros, F. J., Nuyens, V., Baudoux. M., Boudjeltia, K. Z., Ruelle, J. L., Colicis, J., Cantraine, F. & Henry, J. P. (2003) Use of capillary zone electrophoresis for differentiating excessive from moderate alcohol consumption. Clinical Chemistry, 49, 440-449.
9. Wuyts, B., Delanghe, J. R., Kasvosve, I., Wauters, A., Neels, H. & Janssens, J. (2001) Determination of CDT using capillary zone electrophoresis. Clinical Chemistry, 47, 247-255.
10. Arndt, T., Hackler, R., Kleine, T. O. & Gressner, A. M. (1998) Validation by isoelectric focusing of the anion-exchange isotransferrin fractionation step involved in determination of CDT by the CDTect assay. Clinical Chemistry, 44, 27-34.
11. Anton, R. F., Dominick, C., Bigelow, M. & Westby, C. (2001) in collaboration with the CDTect research Group. Comparison of Bio-Rad %CDT TIA and CDTect as laboratory markers of heavy alcohol use and their relationships with GGT. Clinical Chemistry, 47, 1769-1775.
12. Bean, P., Liegmann, K., Lovli, T., Westby, C. & Sundrehagen, E. (1997) Semiautomated procedures for evaluation of CDT in the diagnosis of alcohol abuse. Clinical Chemistry, 43, 983-989.
13. Helander, A., Fors, M. & Zakrisson, B. (2001) Study of Axis-Shield new %CDT immunoassay for quantification of CDT in serum. Alcohol and Alcoholism, 36, 406-412.
14. Helander, A. (1999) Absolute or relative measurement of CDT in serum? Experiences with three immunological assays. Clinical Chemistry, 45, 131-135.
15. Allen, J. P., Litten, R. Z., Anton, R. F. & Cross, G. M. (1994) Carbohydrate-deficient transferrin as a measure of immoderate drinking: remaining issues. Alcoholism: Clinical and Experimental Research, 18, 799-812.
16. Conigrave, K. M., Degenhardt, L. J., Whitfield, J. B., Saunders, J. B., Helander, A. & Tabakoff, B. (2002) CDT, GGT, and AST as markers of alcohol use. The WHO/ISBRA Collaborative Project. Alcoholism: Clinical and Experimental Research, 26, 332-339.
17. Meerkerk, G.-J., Njoo, K. H., Bongers, I. M. B., Trienekens, P. & van Oers, J. A. M. (1998) The specificity of the CDT assay in general practice: the influence of common chronic diseases and medication on the serum CDT concentration. Alcoholism: Clinical and Experimental Research, 22, 908-913.
18. Sillanaukee, P., Strid, N., Allen, J. P. & Litten, R. Z. (2001) Possible reasons why heavy drinking increases CDT. Alcoholism: Clinical and Experimental Research, 25, 34-40.
19. Anton, R. F., Moak, D. H. & Latham, P. (1996) CDT as an indicator of drinking status during a treatment outcome study. Alcoholism: Clinical and Experimental Research, 20, 841-846.
20. Ait-Daoud, N. A., Johnson, B. A., Javors, M. A., Roache, J. D. & Zanca, N. A. (2001) Combining ondansetron and naltrexone effectively treats biologically predisposed alcoholics: corroboration of self-reported drinking by serum CDT, a biomarker. Alcoholism: Clinical and Experimental Research, 25, 847-849.
21. Johnson, B. A., Roache, J. D., Javors, M. A., DiClemente, C. C., Cloninger, C. R., Prihoda, T., Bordnick, P. S., Ait-Daoud, N. A. & Hensler, J. (2003) Ondansetron for reduction of drinking among biologically predisposed alcoholic patients: a randomized controlled trial. Journal of the American Medical Association, 284, 963-971.
22. Anton, R. F., Lieber, C. S. & Tabakoff, B. (2002) CDT and GGT for the detection and monitoring of alcohol use: results from a multisite study. Alcoholism: Clinical and Experimental Research, 26, 1215-1222.
23. de Silva, H. V., Stuart, W. D., Duvic, C. R., Wetterau, J. R., Ray, M. J., Ferguson, D. G., Albers, J. W., Smith, W. R. & Harmony, J. A. K. (1990) A 70-kDa apolipoprotein designated ApoJ is a marker for subclasses of human plasma high density lipoproteins. Journal of Biological Chemistry, 265, 13240-13247.
24. de Silva, H. V., Stuart W. D., Park, U. B., Mao, S. J., Gil, C. M., Wetterau, J. R., Busch, S. J. & Harmony, J. A. (1990) Purification and characterization of apolipoprotein. Journal of Biological Chemistry, 265, 14292-14297.
25. Burkey, B. F., de Silva, H. V. & Harmony, J. A. (1991) Intracellular processing of apolipoprotein J precursor to mature heterodimer. Journal of Lipid Research, 32, 1039-1048.
26. Ghosh, P., Hale, E. A. & Lakshman, R. (1999) Long term ethanol exposure alters the sialylation index of plasma apolipoprotein J (Apo J) in rats. Alcoholism: Clinical and Experimental Research, 23, 720-725.
27. Ghosh, P., Hale, E. A. & Lakshman, M. R. (2001) Plasma sialic acid index of apolipoprotein J (SIJ): a new alcohol intake marker. Alcohol, 25, 173-179.
28. Warren, L. The thiobarbituric acid assay of sialic acids. Journal of Biological Chemistry, 234, 1959.
29. Ponnio, M., Sillanaukee, P. & Franck, J. (2002) Serum sialic acid levels are increased during relapse to alcohol drinking: a pilot study. Alcoholism: Clinical and Experimental Research, 26, 1365-1367.
30. Romppanen, J., Punnonen, K., Anttila, P., Jakobsson, T., Blake, J. & Niemela, O. (2002) Serum sialic acid as a marker of alcohol consumption: effect of liver disease and heavy drinking. Alcoholism: Clinical and Experimental Research, 26, 1234-1238.
31. Sillanaukee, P., Ponnio, M. & Seppa, K. (1999) Sialic acid: new potential marker of alcohol abuse. Alcoholism: Clinical and Experimental Research, 23, 1039-1043.
32. Ponnio, M., Alho, H., Heinala, P., Nikkari, S. T. & Sillanaukee, P. (1999) Serum and saliva levels of sialic acid are elevated in alcoholics. Alcoholism: Clinical and Experimental Research, 23, 1060-1064.
33. Sillanaukee, P., Ponnio, M. & Jaaskelainen, I. P. (1999) Occurrence of sialic acids in healthy humans and different disorders. European Journal of Clinical Investigation, 29, 413-425.
34. Lindberg, G., Rastam, L., Gullberg, B. & Eklund, G. A. (1992) Serum sialic acid concentration predicts both coronary heart disease and stroke mortality: multivariate analyses including 54,385 men and women during 20.5 years follow-up. International Journal of Epidemiology, 21, 253-257.
35. Ozben, T., Nacitarhan, S. & Tuncer, N. (1995) Plasma and urine sialic acid in noninsulin dependent diabetes mellitus. Annals of Clinical Biochemistry, 32, 303-306.
36. Isaksson, A. & Hultberg, B. (1989) Immunoassay of β-hexosaminidase isoenzymes in serum in patients with raised total activities. Clinica Chimica Acta, 183, 155-162.
37. Price, R. G. & Dance, N. (1972) The demonstration of multiple heat stable forms of N-acetyl-β-glucosaminidase in normal human serum. Biochimica et Biophysica Acta, 271, 145-153.
38. Karkkainen, P. (1990) Serum and urinary β-hexosaminidase as markers of heavy drinking. Alcohol and Alcoholism, 25, 365-369.
39. Hultberg, B., Isaksson, A. & Tiderstrom, G. (1980) β-Hexosaminidase, leucine aminopeptidase, cystidylaminopeptidase, hepatic enzymes, and bilirubin in serum of chronic alcoholics with acute ethanol intoxication. Clinica Chimica Acta, 105, 317-323.
40. Stowell, L., Stowell, S., Garrett, N. & Robinson, G. (1997) Comparison of serum β-hexosaminldase isoenzyme B activity with serum CDT and other markers of alcohol abuse. Alcohol and Alcoholism, 32, 703-714.
41. Skrha, J., Perusicova, J., Stolba, P., Stibor, V. & Pav, J. (1987) Comparison of N-acetyl-β-glucosaminidase and albuminuria with clinical finding of microangiopathy in Type I diabetes mellitus. Clinica Chimica Acta, 166, 135-141.
42. Karkkainen, P., Poikolainen, K. & Salaspuro, M. (1990) Serum β-hexosaminidase as a marker of heavy drinking. Alcoholism: Clinical and Experimental Research, 14, 187-190.
43. Hultberg, B., Isaksson, A., Berglund, M. & Moberg, A. L. (1991) Serum β-hexosaminidase isoenzyme: a sensitive marker for alcohol abuse. Alcoholism: Clinical and Experimental Research, 15, 549-552.
44. Hultberg, B., Isaksson, A., Berglund, M. & Alling, C. (1995) Increases and time-course variations in β-hexosaminidase isoenzyme B and CDT in serum from alcoholics are similar. Alcoholism: Clinical and Experimental Research, 1, 452-456.
45. Nystrom, M., Perasalo, J. & Salaspuro, M. (1991) Serum β-hexoasminidase in young university students. Alcoholism: Clinical and Experimental Research, 15, 877-880.
46. Hultberg, B. & Isaksson, A. (1983) Isoenzyme pattern of serum β-hexosaminidase in liver disease, alcohol intoxication, and pregnancy. Enzyme, 30, 166-171.
47. Eriksson, O., Ginsburg, B., Hultberg, B. & Ockerman, P. A. (1972) Influence of age and sex on plasma acid hydrolases. Clinica Chimica Acta, 40, 181-185.
48. Sillanaukee, P. & Olsson, U. (2001) Improved diagnostic classification of alcohol abusers by combining CDT and GGT. Clinical Chemistry, 47, 681-685.